Role of Liquid Biopsy in the Clinic Growing

Targeting Angiogenesis in Mesothelioma: Insights From MAPS and RAMES

A New Standard of Care in EGFR-Positive NSCLC Unresponsive to TKIs?

The OncoKB Precision Oncology Knowledge Base: A Q&A with Dr. Debyani Chakravarty

US FDA greenlights nivolumab for use before surgery for NSCLC

Tumor Growth Rate as a Guide for Precision Lung Cancer Therapy

Patient Perspective: The Promise of Personalized Medicine

Cancer Misinformation: Its Impact on Patients and Mitigation Strategies

A Look at Veliparib Plus Chemotherapy for First-Line Treatment of Advanced NSCLC

TIL Therapy Endures for Carefully Selected Patients: A Q&A with Dr. Benjamin C. Creelan

Early Palliative Care: A European Perspective

As Treatment Options in Lung Cancer Have Expanded, so Have Costs